BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34925369)

  • 1. Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients.
    Caldrer S; Mazzi C; Bernardi M; Prato M; Ronzoni N; Rodari P; Angheben A; Piubelli C; Tiberti N
    Front Immunol; 2021; 12():789735. PubMed ID: 34925369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
    Vigón L; Fuertes D; García-Pérez J; Torres M; Rodríguez-Mora S; Mateos E; Corona M; Saez-Marín AJ; Malo R; Navarro C; Murciano-Antón MA; Cervero M; Alcamí J; García-Gutiérrez V; Planelles V; López-Huertas MR; Coiras M
    Front Immunol; 2021; 12():665329. PubMed ID: 34122423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
    Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
    BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
    Meng L; Xu J; Zhang J; Zhang K; Shang P; Li Q; Li Y; Wang L; Cai B
    Aging (Albany NY); 2021 Mar; 13(6):7723-7732. PubMed ID: 33741750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression.
    Mahmoodpoor A; Hosseini M; Soltani-Zangbar S; Sanaie S; Aghebati-Maleki L; Saghaleini SH; Ostadi Z; Hajivalili M; Bayatmakoo Z; Haji-Fatahaliha M; Babaloo Z; Farid SS; Heris JA; Roshangar L; Rikhtegar R; Kafil HS; Yousefi M
    Mol Immunol; 2021 Oct; 138():121-127. PubMed ID: 34392110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
    Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.
    Rutkowska E; Kwiecień I; Żabicka M; Maliborski A; Raniszewska A; Kłos K; Urbańska W; Klajnowicz I; Rzepecki P; Chciałowski A
    Viruses; 2021 May; 13(5):. PubMed ID: 34064802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.
    Lu Z; Laing ED; Pena DaMata J; Pohida K; Tso MS; Samuels EC; Epsi NJ; Dorjbal B; Lake C; Richard SA; Maves RC; Lindholm DA; Rozman JS; English C; Huprikar N; Mende K; Colombo RE; Colombo CJ; Broder CC; Ganesan A; Lanteri CA; Agan BK; Tribble D; Simons MP; Dalgard CL; Blair PW; Chenoweth J; Pollett SD; Snow AL; Burgess TH; Malloy AMW;
    J Infect Dis; 2021 Dec; 224(12):2010-2019. PubMed ID: 34673956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Immune Profiling Reveals CD56
    Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
    J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.
    Kalicińska E; Szymczak D; Zińczuk A; Adamik B; Smiechowicz J; Skalec T; Nowicka-Suszko D; Biernat M; Bogucka-Fedorczuk A; Rybka J; Martuszewski A; Gozdzik W; Simon K; Wróbel T
    Cells; 2021 May; 10(6):. PubMed ID: 34071149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
    Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
    Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.